Company Filing History:
Years Active: 2012-2013
Title: Innovations of Davinder Tuli in Thyroid Receptor Compounds
Introduction
Davinder Tuli is an accomplished inventor based in Gujarat, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of thyroid receptor compounds. With a total of 2 patents to his name, Tuli's work focuses on creating novel compounds that have therapeutic potential.
Latest Patents
Tuli's latest patents include innovative pyrazole-based thyroid receptor compounds. The first patent discloses a novel thyroid-like compound of formula (I), which has a significantly low binding affinity to thyroid receptors. This characteristic makes the compound considerably devoid of thyrotoxic effects. The invention also outlines the method for its preparation, the composition containing such compounds, and their use as a medicament. These compounds are particularly relevant for treating various disease conditions such as obesity, dyslipidemia, metabolic syndrome, and the co-morbidities associated with metabolic syndrome.
The second patent also focuses on thyroid-like compounds of formula (I), emphasizing their low binding affinity to thyroid receptors and their potential use in treating similar health issues.
Career Highlights
Davinder Tuli is currently associated with Torrent Pharmaceuticals Limited, where he continues to innovate and contribute to the pharmaceutical industry. His work is pivotal in advancing therapeutic options for patients suffering from metabolic disorders.
Collaborations
Tuli collaborates with talented coworkers, including Laxmikant Chhipa and Shitalkumar Pukharaj Zambad, who contribute to the research and development efforts within the company.
Conclusion
Davinder Tuli's innovative work in the field of thyroid receptor compounds showcases his commitment to improving health outcomes through scientific research. His contributions are significant in the ongoing battle against metabolic diseases.